Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1416 | 2574 | 33.6 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | Journal | 147 | 16% | 32% | 828 |
2 | HIV 1 SUBTYPES | Author keyword | 76 | 70% | 2% | 64 |
3 | CIRCULATING RECOMBINANT FORMS | Author keyword | 49 | 94% | 1% | 17 |
4 | AIDS IMUNOL MOL | Address | 32 | 49% | 2% | 47 |
5 | CIRCULATING RECOMBINANT FORM | Author keyword | 26 | 87% | 1% | 13 |
6 | NON B SUBTYPES | Author keyword | 24 | 63% | 1% | 24 |
7 | HIV MOL EPIDEMIOL VIROL GRP | Address | 21 | 90% | 0% | 9 |
8 | HIV SUBTYPE | Author keyword | 19 | 76% | 1% | 13 |
9 | MOL VIROL EPIDEMIOL | Address | 18 | 48% | 1% | 28 |
10 | CRF01_AE | Author keyword | 16 | 51% | 1% | 22 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 SUBTYPES | 76 | 70% | 2% | 64 | Search HIV+1+SUBTYPES | Search HIV+1+SUBTYPES |
2 | CIRCULATING RECOMBINANT FORMS | 49 | 94% | 1% | 17 | Search CIRCULATING+RECOMBINANT+FORMS | Search CIRCULATING+RECOMBINANT+FORMS |
3 | CIRCULATING RECOMBINANT FORM | 26 | 87% | 1% | 13 | Search CIRCULATING+RECOMBINANT+FORM | Search CIRCULATING+RECOMBINANT+FORM |
4 | NON B SUBTYPES | 24 | 63% | 1% | 24 | Search NON+B+SUBTYPES | Search NON+B+SUBTYPES |
5 | HIV SUBTYPE | 19 | 76% | 1% | 13 | Search HIV+SUBTYPE | Search HIV+SUBTYPE |
6 | CRF01_AE | 16 | 51% | 1% | 22 | Search CRF01_AE | Search CRF01_AE |
7 | SUBTYPE F | 15 | 88% | 0% | 7 | Search SUBTYPE+F | Search SUBTYPE+F |
8 | SUBTYPE C | 14 | 37% | 1% | 31 | Search SUBTYPE+C | Search SUBTYPE+C |
9 | SUBTYPE B | 14 | 48% | 1% | 21 | Search SUBTYPE+B | Search SUBTYPE+B |
10 | HIV 1 DIVERSITY | 11 | 65% | 0% | 11 | Search HIV+1+DIVERSITY | Search HIV+1+DIVERSITY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CIRCULATING RECOMBINANT FORM | 170 | 94% | 2% | 61 |
2 | HETERODUPLEX MOBILITY ASSAY | 136 | 67% | 5% | 124 |
3 | INTERSUBTYPE RECOMBINANTS | 96 | 87% | 2% | 47 |
4 | NON B SUBTYPES | 91 | 61% | 4% | 96 |
5 | CIRCULATING RECOMBINANT | 69 | 75% | 2% | 50 |
6 | HIV TYPE 1 | 46 | 33% | 5% | 116 |
7 | CRF02 AG | 44 | 88% | 1% | 21 |
8 | SUBTYPE C | 43 | 31% | 5% | 117 |
9 | GROUP O | 42 | 38% | 3% | 87 |
10 | V3 REGION | 39 | 54% | 2% | 51 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 147 | 16% | 32% | 828 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Update on HIV-1 Acquired and Transmitted Drug Resistance in Africa | 2015 | 3 | 133 | 62% |
Prevalence of HIV-1 subtypes among men who have sex with men in China: a systematic review | 2015 | 2 | 45 | 69% |
The origin and diversity of the HIV-1 pandemic | 2012 | 47 | 108 | 60% |
Update on HIV-1 Diversity in Africa: A Decade in Review | 2012 | 32 | 237 | 80% |
Medical progress: The challenge of HIV-1 subtype diversity | 2008 | 187 | 89 | 58% |
Frequency and implications of HIV superinfection | 2013 | 16 | 59 | 78% |
Understanding the genetic diversity of HIV-1 | 2000 | 211 | 154 | 78% |
Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease | 2011 | 58 | 117 | 49% |
Minireview - Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications | 2007 | 123 | 114 | 43% |
HIV-1 subtypes: epidemiology and significance fov HIV management | 2006 | 119 | 41 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS IMUNOL MOL | 32 | 49% | 1.8% | 47 |
2 | HIV MOL EPIDEMIOL VIROL GRP | 21 | 90% | 0.3% | 9 |
3 | MOL VIROL EPIDEMIOL | 18 | 48% | 1.1% | 28 |
4 | UR36 | 15 | 73% | 0.4% | 11 |
5 | AIDS RETROVIRUS DISCOVERY | 12 | 56% | 0.6% | 15 |
6 | 09NG | 12 | 86% | 0.2% | 6 |
7 | AIDS CARE YNACC | 11 | 100% | 0.2% | 6 |
8 | T LYMPHOTROP VIRUSES | 8 | 100% | 0.2% | 5 |
9 | VIRAL ONCOGENESIS IMMUNOTHER Y | 8 | 100% | 0.2% | 5 |
10 | UMR145 | 7 | 42% | 0.5% | 13 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000287144 | UNITE RETROVIROL MOL//ENTROPY EVOLUTION RATE//HIV 1 MOTHER TO CHILD TRANSMISSION |
2 | 0.0000208697 | K65R//TRANSMITTED DRUG RESISTANCE//HIV 1 DRUG RESISTANCE |
3 | 0.0000108403 | HIV 2//HIV 2 INFECTION//GUINEA BISSAU |
4 | 0.0000092316 | HCV CORE ANTIGEN//HCV CORE ANTIGEN ASSAY//HCV RNA STABILITY |
5 | 0.0000083859 | ACUTE HIV INFECTION//ACUTE RETROVIRAL SYNDROME//BED CEIA |
6 | 0.0000057930 | CCR5//MARAVIROC//CCR5 ANTAGONIST |
7 | 0.0000055623 | LOSS TO FOLLOW UP//KNOWLEDGE TRANSLAT UNIT//HLTH ECON EPIDEMIOL OFF |
8 | 0.0000055284 | MOLECULAR CLOCK//RELAXED CLOCK//PHYLODYNAMICS |
9 | 0.0000054887 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER |
10 | 0.0000053709 | HIV AIDS ABORAT//THAILAND MOPH US CDC ABORAT//AIDS CASES |